Kenneth Rainin announces 2011 Innovator Awards Program for Inflammatory Bowel Disease

The Kenneth Rainin Foundation announced today its 2011 Innovator Awards Program for Inflammatory Bowel Disease. The Program, now in its second year, is designed to accelerate the pace of discovery in IBD research.  Approximately four million people worldwide suffer from some form of IBD.  Although the disease can occur at any age, the peak onset is between the ages of 15 to 30.  Approximately 10% of the cases occur in children, which can cause delayed puberty and growth problems.

The Program is open to tenure track professors (or the equivalent) at all levels from any scientific discipline and from any non-profit research institutions worldwide.  Interdisciplinary collaboration is strongly encouraged.

Letters of Inquiry (LOI) will be accepted online January 15 - February 15, 2011.  The one-page LOI must include the basic idea and the central experiment.  A biosketch will also be required.  The Foundation's Scientific Advisory Board will determine which applicants will be invited to submit a full application.  Applicant selection will primarily be based on the project's close alignment with the Innovator Awards Program's criteria.  Full applications, which will consist of an expanded LOI (up to three pages), two pages of science and a budget, will be due by May 1st.

The Program's key components for funding consideration include innovation, collaboration, scientific merit and a high potential for success as well as projects that, due to their innovative nature, may not be eligible for funding from the National Institutes of Health (NIH) or other more traditional sources.  

SOURCE The Kenneth Rainin Foundation

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Scientists uncover two Crohn’s disease subtypes using lab-grown intestines, offering hope for personalized therapies